NASDAQ: CSTL · Industrial Applications and Services · 14 alerts · CIK 1447362
Share price
$32.75Close, Nov 16
Market cap
$1.01B
Shares outstanding
30.82MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Medical LaboratoriesSIC 8071
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Castle Biosciences Inc filings on SEC EDGAR ↗
Castle Biosciences Chief Commercial Officer Tobin W. Juvenal Sells $112K of Stock
Tobin W. Juvenal, Chief Commercial Officer, sold 3,195 shares of Castle Biosciences Inc at $35.07 a share, worth $112K in total on Nov 11, 2026. Shares held after the trade: 32,737 (-8.9%).
Castle Biosciences Chief Commercial Officer Tobin W. Juvenal Sells $207K of Stock
Tobin W. Juvenal, Chief Commercial Officer, sold 6,116 shares of Castle Biosciences Inc at $32.67 to $35.04 a share (average $33.77) in 2 transactions, worth $207K in total between Nov 9, 2026 and Nov 11, 2026. Shares held after the trade: 32,737 (-8.0%).
Castle Biosciences Pres. & Chief Exec. Officer Derek J. Maetzold Sells $523K of Stock
Derek J. Maetzold, Pres. & Chief Exec. Officer, sold 14,496 shares of Castle Biosciences Inc at $36.01 to $36.81 a share (average $36.10) in 6 transactions, worth $523K in total on Nov 2, 2026. Shares held after the trade: 1,396 (-18.9%).
Castle Biosciences Chief Commercial Officer Tobin W. Juvenal Sells $240K of Stock
Tobin W. Juvenal, Chief Commercial Officer, sold 6,578 shares of Castle Biosciences Inc at $35.58 to $36.62 a share (average $36.42) in 2 transactions, worth $240K in total on Oct 28, 2026. Shares held after the trade: 38,853 (-12.1%).
Castle Biosciences Chief Commercial Officer Tobin W. Juvenal Sells $109K of Stock
Tobin W. Juvenal, Chief Commercial Officer, sold 3,288 shares of Castle Biosciences Inc at $33.08 a share, worth $109K in total on Oct 26, 2026. Shares held after the trade: 45,431 (-6.7%).
Castle Biosciences Pres. & Chief Exec. Officer Derek J. Maetzold Sells $463K of Stock
Derek J. Maetzold, Pres. & Chief Exec. Officer, sold 14,496 shares of Castle Biosciences Inc at $31.91 a share, worth $463K in total on Oct 19, 2026. Shares held after the trade: 4,114 (-39.8%).
Castle Biosciences Chief Commercial Officer Tobin W. Juvenal Sells $111K of Stock
Tobin W. Juvenal, Chief Commercial Officer, sold 3,288 shares of Castle Biosciences Inc at $33.64 a share, worth $111K in total on Oct 12, 2026. Shares held after the trade: 48,719 (-6.3%).
Castle Biosciences Pres. & Chief Exec. Officer Derek J. Maetzold Sells $516K of Stock
Derek J. Maetzold, Pres. & Chief Exec. Officer, sold 14,496 shares of Castle Biosciences Inc at $35.57 a share, worth $516K in total on Oct 5, 2026. Shares held after the trade: 6,832 (-28.5%).
Castle Biosciences COO Kristen M. Oelschlager Sells $149K of Stock
Kristen M. Oelschlager, COO, sold 4,153 shares of Castle Biosciences Inc at $35.75 to $36.38 a share (average $35.95) in 2 transactions, worth $149K in total on Oct 1, 2026. Shares held after the trade: 13,356 (-9.2%).
Castle Biosciences Chief Commercial Officer Tobin W. Juvenal Sells $232K of Stock
Tobin W. Juvenal, Chief Commercial Officer, sold 6,577 shares of Castle Biosciences Inc at $34.20 to $35.50 a share (average $35.29) in 2 transactions, worth $232K in total between Sep 29, 2026 and Sep 30, 2026. Shares held after the trade: 52,007 (-1.9%).